Cargando…
Real‐world emetic risk of chemotherapy and the corresponding antiemetic therapy in Japan: A study based on a nationwide database
BACKGROUND: Chemotherapy‐induced nausea and vomiting (CINV) is a major concern of patients with cancer, leading to suboptimal treatment. AIM: This study assessed the emetic risk associated with intravenous and oral chemotherapy and the prophylactic antiemetic drugs by cancer type in a real‐world set...
Autores principales: | Okuyama, Ayako, Boku, Narikazu, Higashi, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955058/ https://www.ncbi.nlm.nih.gov/pubmed/34176233 http://dx.doi.org/10.1002/cnr2.1482 |
Ejemplares similares
-
Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis
por: Aogi, Kenjiro, et al.
Publicado: (2020) -
Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk
por: Shimokawa, Mototsugu, et al.
Publicado: (2021) -
Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs.
por: McMillan, C., et al.
Publicado: (1991) -
Antiemetics and Cancer Chemotherapy
por: Wilkinson, P.W.
Publicado: (1983) -
Anti-emetics and cancer chemotherapy.
por: Leonard, R. C., et al.
Publicado: (1990)